Hankyel Park

Array ( [id] => 1140819 [patent_doc_number] => 06777178 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Antibodies for judging possibility of the onset of bovine leukemia' [patent_app_type] => B1 [patent_app_number] => 09/763625 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3353 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777178.pdf [firstpage_image] =>[orig_patent_app_number] => 09763625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377301 [patent_doc_number] => 20020119457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'End selection in directed evolution' [patent_app_type] => new [patent_app_number] => 09/867262 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 41532 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119457.pdf [firstpage_image] =>[orig_patent_app_number] => 09867262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335218 [patent_doc_number] => 06593111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Directional assembly of large viral genomes and chromosomes' [patent_app_type] => B2 [patent_app_number] => 09/862847 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10076 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593111.pdf [firstpage_image] =>[orig_patent_app_number] => 09862847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527923 [patent_doc_number] => 06479282 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Hbc expression and diagnostic and therapeutic uses' [patent_app_type] => B1 [patent_app_number] => 09/851120 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13537 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479282.pdf [firstpage_image] =>[orig_patent_app_number] => 09851120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1227833 [patent_doc_number] => 06696244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'G-coupled receptors associated with retroviral entry into cells, and therapeutic uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/852156 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 31505 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696244.pdf [firstpage_image] =>[orig_patent_app_number] => 09852156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032154 [patent_doc_number] => 20020018808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Vaccines against sterols' [patent_app_type] => new [patent_app_number] => 09/846776 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12960 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018808.pdf [firstpage_image] =>[orig_patent_app_number] => 09846776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062929 [patent_doc_number] => 20020031521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Method of DNA transfer' [patent_app_type] => new [patent_app_number] => 09/842073 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25164 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031521.pdf [firstpage_image] =>[orig_patent_app_number] => 09842073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1542115 [patent_doc_number] => 06372455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Recombinant vaccinia viral vectors' [patent_app_type] => B1 [patent_app_number] => 09/837997 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2554 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372455.pdf [firstpage_image] =>[orig_patent_app_number] => 09837997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506830 [patent_doc_number] => 06440659 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Inhibitors of retroviral protease as inducers of reversible insulin resistance in vitro and in vivo' [patent_app_type] => B1 [patent_app_number] => 09/838548 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 10191 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440659.pdf [firstpage_image] =>[orig_patent_app_number] => 09838548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381064 [patent_doc_number] => 20020119922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Peptides for inhibition of HIV infection' [patent_app_type] => new [patent_app_number] => 09/834628 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4335 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119922.pdf [firstpage_image] =>[orig_patent_app_number] => 09834628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645810 [patent_doc_number] => 06472159 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Use of an amphipathic compound for providing an adjuvant to a subunit vaccine' [patent_app_type] => B1 [patent_app_number] => 09/720863 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1757 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472159.pdf [firstpage_image] =>[orig_patent_app_number] => 09720863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529171 [patent_doc_number] => 20020192822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Herpes simplex virus ICP4 is an inhibitor of apoptosis ' [patent_app_type] => new [patent_app_number] => 09/825288 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15027 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192822.pdf [firstpage_image] =>[orig_patent_app_number] => 09825288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935936 [patent_doc_number] => 20020061517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Adenovirus carrying gag gene HIV vaccine' [patent_app_type] => new [patent_app_number] => 09/818443 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 13542 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061517.pdf [firstpage_image] =>[orig_patent_app_number] => 09818443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559330 [patent_doc_number] => 06436648 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Chimeric viral proteins' [patent_app_type] => B1 [patent_app_number] => 09/817413 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 13506 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436648.pdf [firstpage_image] =>[orig_patent_app_number] => 09817413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934411 [patent_doc_number] => 20010055755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'Dendritic marker-expressing macrophage cultures and methods for reactivating latent HCMV' [patent_app_type] => new [patent_app_number] => 09/810328 [patent_app_country] => US [patent_app_date] => 2001-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16741 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20010055755.pdf [firstpage_image] =>[orig_patent_app_number] => 09810328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514307 [patent_doc_number] => 06420141 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids' [patent_app_type] => B1 [patent_app_number] => 09/582519 [patent_app_country] => US [patent_app_date] => 2001-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6893 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420141.pdf [firstpage_image] =>[orig_patent_app_number] => 09582519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1587489 [patent_doc_number] => 06482413 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Vitamin B12 biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines' [patent_app_type] => B1 [patent_app_number] => 09/795979 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11477 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482413.pdf [firstpage_image] =>[orig_patent_app_number] => 09795979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101365 [patent_doc_number] => 06815158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'Methods for judging resistance to the onset of bovine leukemia' [patent_app_type] => B2 [patent_app_number] => 09/794366 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7585 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815158.pdf [firstpage_image] =>[orig_patent_app_number] => 09794366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829425 [patent_doc_number] => 20020068813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Sulfated CCR5 peptides for HIV-1 infection' [patent_app_type] => new [patent_app_number] => 09/796202 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27212 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068813.pdf [firstpage_image] =>[orig_patent_app_number] => 09796202 [rel_patent_id] =>[rel_patent_doc_number] =>)